<DOC>
	<DOCNO>NCT00763360</DOCNO>
	<brief_summary>The objective study ass DisCoVisc Ophthalmic Viscosurgical Device ( OVD ) compare Healon Amvisc Plus protection corneal endothelial cell , ability maintain anterior chamber space , routine cataract surgery .</brief_summary>
	<brief_title>To Compare Ability DiscoVisc® OVD Protect Corneal Endothelium Maintain Anterior Chamber Space With Healon® Amvisc® PLUS During Cataract Surgery .</brief_title>
	<detailed_description />
	<mesh_term>Cataract</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>Patients able understand sign document informed consent ; Patients age ≥49 year agerelated cataract formation ; Patients plan undergo surgical removal cataract phacoemulsification implantation posterior chamber intraocular lens ; Patients healthy eye exclude formation cataract . pseudoexfoliation syndrome glaucoma zonular compromise operative eye ; A congenital ocular anomaly ( e.g. , aniridia , congenital cataract ) operative eye ; Iris atrophy operative eye ; Glaucoma ( include pseudoexfoliation pigmentary ) cause compromised outflow operative eye ; Any abnormality prevents reliable Goldmann applanation tonometry operative eye ; Ocular hypertension ( lntraocular Pressure ( IOP ) &gt; 21 mmHg ) operative eye baseline exam ; Corneal abnormality result poor endothelial cell photograph prevents reliable endothelial cell density measurement ; Baseline endothelial cell density &lt; 1500 cells/mm2 , operative eye ; Planned multiple procedure cataract/Intraocular Lens ( IOL ) implantation surgery ( e.g. , trabeculoplasty , corneal transplant ) . NOTE : A minor relaxing keratotomy Patients 48 year age younger ; Proliferative diabetic retinopathy operative eye ; Uncontrolled diabetes mellitus ; Marfan 's Syndrome ; An ocular disease and/or condition may compromise result ; A history chronic recurrent inflammatory eye disease ( e.g . iritis , scleritis , uveitis , iridocyclitis , rubeosis iritis ) operative eye ; Lens correction astigmatism may perform ; Previous ocular trauma operative eye ( include previous intraocular surgery traumatic cataract ) . NOTE : history noninvasive laser surgery ( exception laser treatment PDR ) acceptable inclusion ; A nonfunctional fellow eye ; Participation clinical study within 30 day surgery</criteria>
	<gender>All</gender>
	<minimum_age>49 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Cataract</keyword>
</DOC>